GGrantIndex
Sort

326,823 grants matching clinical trial

A Gene therapeutic approach to stable suppression of HIV-1 replication

$2,225,513
Michael R. Farzan · Harvard Medical School · P01 · FY2012 · AI

Cancer Center Support Grant

$2,225,352
Michael A Friedman · Beckman Research Institute/City Of Hope · P30 · FY2012 · CA

Cancer Center Support Grant

$2,225,352
Michael A Friedman · Beckman Research Institute/City Of Hope · P30 · FY2011 · CA

Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer

$2,225,217
Barbara Burtness · Yale University · P50 · FY2023 · DE

Phase lll Study of the Effects of Selenium on Ademonas

$2,225,116
M. Peter Lance · University Of Arizona · P01 · FY2009 · CA

Statistical Models and Mechanisms Linking Biomarkers of Aging to Cognitive-Physical Decline and Dementia

$2,224,522
Michelle Denise Shardell · University Of Maryland Baltimore · RF1 · FY2022 · NS

Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making

$2,224,512
Peter J O'Dwyer · Ecog-Acrin Medical Research Foundation · U01 · FY2023 · FD

Mayo Clinic Multiple Myeloma SPORE

$2,224,423
Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2025 · CA

Research Center for Child Well-Being

$2,224,382
Ronald J Prinz · University Of South Carolina At Columbia · P20 · FY2022 · GM

Columbia Collaborative HIV/AIDS Clinical Trials Unit

$2,224,347
Magdalena Elzbieta Sobieszczyk · Columbia University Health Sciences · UM1 · FY2023 · AI

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs

$2,224,345
Thomas Quinn · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Metabolic Control Analysis

$2,224,240
Richard L Veech · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA

Surgical pathology-enabled augmented reality for head and neck tumor resection with deformation modeling

$2,223,201
Jie Ying Wu · Vanderbilt University · R01 · FY2025 · EB

Clinical and Translational Science Collaborative of Cleveland

$2,223,126
Michael W. Konstan · Case Western Reserve University · KL2 · FY2016 · TR

Psychiatry Clinical Research Training-NIMH Office of the Clinical Director

$2,222,785
Maryland Pao · National Institute Of Mental Health · ZIE · FY2025 · MH

Pharmacogenetics of Phase II Drug Metabolizing Enzymes

$2,222,489
Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2010 · GM

Increasing the therapeutic index of brain tumor treatment through innovative FLASH radiotherapy

$2,222,254
Charles Limoli · University Of California-Irvine · P01 · FY2022 · CA

Race / Ethncicity, Hypertension and Prevention of VCID and Stroke after Intracerebral Hemmorrhage

$2,222,086
Jonathan Rosand · Massachusetts General Hospital · R01 · FY2022 · NS

Baylor mental Retardation and Developmental Disabilitie*

$2,222,059
Huda Y Zoghbi · Baylor College Of Medicine · P30 · FY2007 · HD

Improving Equitable Access to Neurology Care to Achieve Pharmacoequity for Older Adults with ADRD

$2,221,917
Utibe R. Essien · University Of California Los Angeles · RF1 · FY2025 · NS

Anti-NMDA receptor antibodies in brain dysfunction: lessons from lupus

$2,221,830
Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2012 · AI

Autoimmune Diseases Group

$2,221,470
Lynette Keyes-Elstein · Rho Federal Systems Division, Inc. · UM2 · FY2021 · AI

HALF-PINT: Heart and Lung Failure - Pediatric INsulin Titration trial - CCC

$2,221,437
Michael Agus · Boston Children'S Hospital · U01 · FY2011 · HL

Costimulatory Mechanisms of Autoimmunity (Composite)

$2,220,927
David A. Hafler · Yale University · P01 · FY2010 · AI

TUBERCULOSIS PREVENTION IN CHILDREN TWO TO LESS THAN 13 YEARS OF AGE WITH AND WITHOUT HIV

$2,220,803
Barbara Driver · Westat, Inc. · N01 · FY2023 · HD